131 MET ECD shedding and poor DFS Supplementary figure 2: N-terminal MET immunoreactivities observed for p170 and p145β using A2H2-3 under non-reducing conditions using various cell lines. A reducing blot cannot be generated using this antibody as its epitope is abolished under these conditions. A. MET positive (H441 and H1299) and negative (SNU-1) control cell lines. B. The MET antibody validation cell line panel. C. A series of head and neck squamous cell carcinoma cell lines. 4
RkJQdWJsaXNoZXIy MTk4NDMw